This week's episode focuses on early-stage and locally advanced non-small cell lung cancer - staging, pathology, local and systemic therapy. Before we start, the usual caveat: the treatment landscape of NSCLC is changing FAST, which is exciting, but know that the boards run a few years behind. The big shifts since our last episode are the move to 9th-edition TNM staging and the arrival of four different perioperative chemo+immunotherapy regimens. Shout out to Dr. Bharathi Muthusamy for review...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Two Onc Docs
Breast Cancer Screening, Prevention & Intro 2026 UPDATE
ctDNA & MRD: Current Applications, Limitations & What’s Next
ctDNA, Liquid Biopsies, Methylation, NGS: What Does It All Mean?
Metastatic Non-Small Cell Lung Cancer 2026 UPDATE
Get summaries like this every morning.
Free AI-powered recaps of Two Onc Docs and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.